Glaxo Decides Not To Pursue U.K. Flu Awareness Campaign For Relenza
Executive Summary
The potential negative impact on the U.K.' s National Health Service drug budget may be one factor behind Glaxo Wellcome's decision not to launch a flu awareness campaign for its neuraminidase inhibitor Relenza (zanamivir) in the U.K.
You may also be interested in...
Compulsory Licenses For "Unjustifiably High" Drugs Sought By Rep. Brown
A call for compulsory drug licensing is reappearing in the House with roots from regulation of the cable industry.
P&U Detrol Campaign Finds Detractors in U.K Consumer Group
The U.K.' s Consumer Association has asked the Blair government to review its policies on Rx advertising in the wake of the disease awareness TV campaign for Pharmacia & Upjohn's overactive bladder therapy Detrol/Detrusitol (tolterodine), launched Sept. 1.
P&U Detrol Campaign Finds Detractors in U.K Consumer Group
The U.K.' s Consumer Association has asked the Blair government to review its policies on Rx advertising in the wake of the disease awareness TV campaign for Pharmacia & Upjohn's overactive bladder therapy Detrol/Detrusitol (tolterodine), launched Sept. 1.